20
Participants
Start Date
March 21, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2026
Gamma Delta T-Cell Infusion
Donor cells will be processed in a laboratory, where T-cell subtype called γδ (gamma delta) T-cells will be isolated and expanded in number. These T-cells expanded in a laboratory will be infused in participants who are otherwise at high risk of AML recurrence after alloHCT.
Moffitt Cancer Center, Tampa
Florida Department of Health
OTHER_GOV
H. Lee Moffitt Cancer Center and Research Institute
OTHER